1. Home
  2. SGHT vs ACB Comparison

SGHT vs ACB Comparison

Compare SGHT & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • ACB
  • Stock Information
  • Founded
  • SGHT 2011
  • ACB 2013
  • Country
  • SGHT United States
  • ACB Canada
  • Employees
  • SGHT N/A
  • ACB N/A
  • Industry
  • SGHT Medical Specialities
  • ACB Pharmaceuticals and Biotechnology
  • Sector
  • SGHT Health Care
  • ACB Health Care
  • Exchange
  • SGHT Nasdaq
  • ACB Nasdaq
  • Market Cap
  • SGHT 304.4M
  • ACB 257.9M
  • IPO Year
  • SGHT 2021
  • ACB N/A
  • Fundamental
  • Price
  • SGHT $2.89
  • ACB $3.90
  • Analyst Decision
  • SGHT Buy
  • ACB Hold
  • Analyst Count
  • SGHT 7
  • ACB 1
  • Target Price
  • SGHT $5.10
  • ACB N/A
  • AVG Volume (30 Days)
  • SGHT 260.5K
  • ACB 717.6K
  • Earning Date
  • SGHT 03-06-2025
  • ACB 02-06-2025
  • Dividend Yield
  • SGHT N/A
  • ACB N/A
  • EPS Growth
  • SGHT N/A
  • ACB N/A
  • EPS
  • SGHT N/A
  • ACB N/A
  • Revenue
  • SGHT $79,543,000.00
  • ACB $219,835,671.00
  • Revenue This Year
  • SGHT $2.13
  • ACB $19.90
  • Revenue Next Year
  • SGHT $7.99
  • ACB $5.80
  • P/E Ratio
  • SGHT N/A
  • ACB N/A
  • Revenue Growth
  • SGHT N/A
  • ACB 13.15
  • 52 Week Low
  • SGHT $2.68
  • ACB $2.84
  • 52 Week High
  • SGHT $8.45
  • ACB $9.35
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 26.68
  • ACB 35.99
  • Support Level
  • SGHT $2.68
  • ACB $3.91
  • Resistance Level
  • SGHT $3.34
  • ACB $4.04
  • Average True Range (ATR)
  • SGHT 0.16
  • ACB 0.22
  • MACD
  • SGHT -0.03
  • ACB -0.04
  • Stochastic Oscillator
  • SGHT 20.38
  • ACB 9.54

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About ACB Aurora Cannabis Inc.

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.

Share on Social Networks: